From the Office Suite to Cell Block C: Potential Criminal and Regulatory Implications of Pharma/Biotech/Device Products Liability Lawsuits

Size: px
Start display at page:

Download "From the Office Suite to Cell Block C: Potential Criminal and Regulatory Implications of Pharma/Biotech/Device Products Liability Lawsuits"

Transcription

1 From the Office Suite to Cell Block C: Potential Criminal and Regulatory Implications of Pharma/Biotech/Device Products Liability Lawsuits BUTLER SNOW 1

2 UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION UNITED STATES OF AMERICA Case No. v. HEALTHCARE CORPORATION, AND JOHN DOE DISTRIBUTORS Violation: Title 18, United States Code, Section 287 Defendants. INDICTMENT BUTLER SNOW 2

3 BELOW THE SURFACE: CIVIL CASES, CRIMINAL IMPLICATIONS UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION JANE DOE Case No. Plaintiff, v. DEMAND FOR JURY TRIAL HEALTHCARE CORPORATION, AND JOHN DOE DISTRIBUTORS Defendants. COMPLAINT BUTLER SNOW 3

4 DOJ POLICY: CRIMINAL AND CIVIL COORDINATION It is Department of Justice policy that criminal prosecutors and civil attorneys should coordinate with one another and with agency attorneys Early and effective coordination is critical Parallel investigations maximize our potential to secure the appropriate resolution, whether it be criminal prosecution, financial penalties, restitution, asset forfeiture or federal program exclusion or debarment. - Assistant U.S. Attorney General Leslie Caldwell, April 14, 2015 BUTLER SNOW 4

5 DOJ POLICY: CRIMINAL PROSECUTION NECESSARY [T]here is a critical need for criminal prosecutions, even if conduct could be pursued civilly or through regulatory action. [O]ften it is the threat of criminal prosecution that deters potential wrongdoers. The stakes in criminal prosecutions are high often involving prison time for individuals, and potential collateral consequences for companies - Assistant U.S. Attorney General Leslie Caldwell, April 14, 2015 BUTLER SNOW 5

6 DOJ: PROSECUTING INDIVIDUALS HIGH PRIORITY The prosecution of individuals including corporate executives for criminal wrongdoing continues to be a high priority for the [Justice] department. [C]orporations do not act criminally, but for the actions of individuals. And, the Criminal Division intends to prosecute those individuals, whether they are sitting on a sales desk or in a corporate suite. - Deputy Assistant U.S. Attorney General Sung-Hee Suh, Jan. 20, 2015 BUTLER SNOW 6

7 PROSECUTIONS ARE ON THE RISE Pharmaceutical Industry has surpassed Defense Industry in number of False Claims Act ( FCA ) prosecutions From , pharmaceutical companies accounted for 25% of all FCA settlements, compared to 11% for Defense Industry In 2013, DOJ and HHS collected $3.7 billion in fines from pharmaceutical companies BUTLER SNOW 7

8 IMPACT OF PLAINTIFFS BAR AND MEDIA Lawyers Create Big Paydays by Coaxing Attorneys General to Sue DEC. 18, 2014 Crime and Punishment: Corporations are paying record fines for breaking ever more complex laws. Critics, though, want to see executives in the dock. Feb. 3, 2015 Is Big Pharma Addicted to Fraud? July 29, 2013 BUTLER SNOW 8

9 KEY QUESTIONS 1. What criminal and regulatory issues does this civil case/litigation raise? 2. How can we prepare the Company for an investigation or prosecution? BUTLER SNOW 9

10 1. What criminal and regulatory issues does this civil case/litigation raise? BUTLER SNOW 10

11 THREATS AT EVERY STAGE Pre-Clinical Clinical Trials Manufacturing Launch/Post- Marketing Good Laboratory Practices ( GLP ) USPTO Economic Espionage Act (Theft of Trade Secrets) Allegations of Fraud o Collection of Data o Reporting of Data to FDA o Reporting Adverse Events to FDA o Study Results o SEC Current Good Manufacturing Practice ( cgmp ) False Claims Act/FDCA Fraud-based charges Off-label Promotion Failure to Recall FCPA FTC RICO Spoliation 1 3 YEARS 2 10 YEARS Up to 7 YEARS INDEFINITELY Investigational New Drug (IND) Application Submitted Clinical Clinical Trials Trials New Drug Application (NDA) Submitted NDA Approval BUTLER SNOW 11

12 COMMON ALLEGATIONS IN CIVIL CASES THAT MAY GIVE RISE TO CRIMINAL LIABILITY False Statements (18 U.S.C. 1001) o Felony to knowingly and willfully make material false statement to U.S. Government, including FDA Falsifying, concealing, or covering up a material fact by any trick, scheme, or device Making materially false, fictitious or fraudulent statements or representations Making or using a false writing or document with knowledge that it contains materially false, fictitious or fraudulent statements o Stand-alone charge BUTLER SNOW 12

13 BROAD USE OF SECTION 1001 False statements made to FDA in company s annual reports re: drug stability testing program False statements made to FBI and SEC during interview re: defendant s alleged insider trading of biotech company s stock False statements made re: pacemaker testing to Medicare agents conducting an audit investigating fraud BUTLER SNOW 13

14 COMMON ALLEGATIONS IN CIVIL CASES THAT MAY GIVE RISE TO CRIMINAL LIABILITY Conspiracy to defraud the U.S. Government (18 U.S.C. 371) o Conspiracy to impair, obstruct, or defeat the lawful functions of any department of the Government o By deceit, craft, or trickery, or at least by means that are dishonest No requirement that Government suffer any loss Punishable by up to 5 years imprisonment BUTLER SNOW 14

15 COMMON ALLEGATIONS IN CIVIL CASES THAT MAY GIVE RISE TO CRIMINAL LIABILITY cgmp Violations Drug companies should be aware that failing to adhere to good manufacturing practices subjects them to penalties and prosecution. - First Assistant U.S. Attorney Louis Lappen, E.D.P.A., Mar. 10, 2015 BUTLER SNOW 15

16 COMMON ALLEGATIONS IN CIVIL CASES THAT MAY GIVE RISE TO CRIMINAL LIABILITY cgmp Regs (21 CFR 210; 211) cover, inter alia: Organization and Personnel Buildings/Facilities Equipment Containers/Closures Production Controls Packaging/Labeling Control Holding and Distribution Laboratory Controls Records/Reports Return/Salvaged Product BUTLER SNOW 16

17 COMMON ALLEGATIONS IN CIVIL CASES THAT MAY GIVE RISE TO CRIMINAL LIABILITY Food, Drug and Cosmetic Act ( FDCA ): prohibits distribution of adulterated or misbranded drugs or medical devices Strict liability criminal offenses Park doctrine Death Sentence Repeated violations may result in increase from misdemeanor to felony Prison and fines (up to $1 million for medical devices) Also subject to criminal prosecution for failing to report data to the FDA BUTLER SNOW 17

18 EXAMPLE OF FDCA PROSECUTION Major drug manufacturer pled guilty to criminal charges for violating FDCA, including, inter alia: o failing to report certain safety data about a drug o providing inadequate directions for use of another drug o participating in a misleading medical journal article that made false efficacy claims re: yet another drug o failing to report data from two other studies in which the last drug failed to demonstrate efficacy in certain patients Over $1 billion in criminal fines and $2 billion in civil penalties Criminal plea required compliance commitments and certifications from president and board of directors BUTLER SNOW 18

19 COMMON ALLEGATIONS IN CIVIL CASES THAT MAY GIVE RISE TO CRIMINAL LIABILITY False Claims Act ( FCA ) (18 U.S.C. 287): o Makes it a crime to knowingly submit a false, fictitious, or fraudulent claim to U.S. Government Up to 5 years in prison and fines Civil penalties may include treble damages Qui Tam ( Whistleblower ) o Filed under seal o Incentive: Relator can get up to 30% of fines collected by government BUTLER SNOW 19

20 HYBRID PROSECUTIONS: FULL ASSAULT Drug company pled guilty to violating FDCA by manufacturing adulterated drugs at one of its foreign facilities, and violating the false statements statute by making false statements to the FDA The criminal charges alleged: o cgmp deviations in the manufacture of ingredients and finished products o Improper stability testing for certain batches of drugs o Improper storage of drug samples at correct temperatures and humidity o False statements made to the FDA in Annual Reports regarding the dates on which stability tests were conducted o Failure to disclose improper storage practices to the FDA Paid a criminal fine of $150 million and $350 million in civil penalties under the FCA. BUTLER SNOW 20

21 COMMON ALLEGATIONS IN CIVIL CASES THAT MAY GIVE RISE TO CRIMINAL LIABILITY Foreign Corrupt Practices Act ( FCPA ) : o Makes it a crime to bribe a foreign government official to obtain or retain business or to secure any improper business advantage Two Key Provisions o Anti-bribery o Accounting/Books and Records Challenges o Broad definition of foreign official o Estimated that well over 1/3 of all pharmaceutical sales occur in overseas markets o Corporate structure/subsidiaries o Relator can get up to 30% of fines collected by government BUTLER SNOW 21

22 EXAMPLES OF FCPA PROSECUTIONS SEC: Enforcement of the Foreign Corrupt Practices Act (FCPA) continues to be a high priority area for the SEC. 2013: SEC charged company with violating the FCPA by bribing doctors and other government officials in five countries to obtain or retain business and make $7.5 million in illicit profits Company agreed to pay more than $13.2 million to settle the SEC's charges BUTLER SNOW 22

23 EXAMPLES OF FCPA PROSECUTIONS SEC charged company for improper payments its subsidiaries made to foreign government officials to win business in Russia, Brazil, China, and Poland. Company agreed to pay more than $29 million to settle the charges. SEC charged company for illegal payments made by its subsidiaries to foreign officials to obtain regulatory approvals, sales, and increased prescriptions for its products. Company agreed to pay $45 million to settle. BUTLER SNOW 23

24 2. How can we help prepare the Company for an investigation or prosecution? BUTLER SNOW 24

25 EXPECT THE UNEXPECTED EXPECTED Understand the product lifecycle, anticipate pitfalls at each stage, and issue spot Review/Update internal policies and processes for government communications, disclosures, and reports Develop internal guides, protocols, or checklists tailored to specific departments and specific stages in product lifecycle (e.g., R&D, marketing, finance departments) Never assume executives or employees know what constitutes a violation BUTLER SNOW 25

26 UNDERSTAND THE MANUFACTURING PROCESS For DOJ, I didn t know is never the answer Review Guidance to understand FDA expectations Be good... and be seen being good Ensure Company openly and publicly prioritizes cgmp The company you keep Know suppliers and partners, particularly those involved in manufacturing, production, packaging, shipping, and holding Encourage and incentivize employees to report known or suspected cgmp violations Investigate complaints/issues immediately Document follow-up and steps to correct BUTLER SNOW 26

27 QUESTIONS? BUTLER SNOW 27

MATTHEW T. SCHELP. St. Louis, MO office:

MATTHEW T. SCHELP. St. Louis, MO office: MATTHEW T. SCHELP Partner St. Louis, MO office: 314.480.1772 email: matthew.schelp@ Overview A former federal prosecutor, Matt concentrates his practice in the areas of compliance, internal investigations,

More information

AGENCY POLICY. IDENTIFICATION NUMBER: CCD001 DATE APPROVED: Nov 1, 2017 POLICY NAME: False Claims & Whistleblower SUPERSEDES: May 18, 2009

AGENCY POLICY. IDENTIFICATION NUMBER: CCD001 DATE APPROVED: Nov 1, 2017 POLICY NAME: False Claims & Whistleblower SUPERSEDES: May 18, 2009 IDENTIFICATION NUMBER: CCD001 DATE APPROVED: Nov 1, 2017 POLICY NAME: False Claims & Whistleblower SUPERSEDES: May 18, 2009 Provisions OWNER S DEPARTMENT: Compliance APPLICABILITY: All Agency Programs

More information

Corporate Compliance Topic: False Claims Act and Whistleblower Provisions

Corporate Compliance Topic: False Claims Act and Whistleblower Provisions Purpose: INDEPENDENT LIVING, Inc. (also referred to as ILI, ) is committed to prompt, complete and accurate billing of all services provided to individuals. ILI and its employees, contractors and agents

More information

Panelists. ABA 31 st Annual National Institute on White Collar Crime. Healthcare Fraud and Abuse Panel

Panelists. ABA 31 st Annual National Institute on White Collar Crime. Healthcare Fraud and Abuse Panel Prepared for ABA 31 st Annual National Institute on White Collar Crime Healthcare Fraud and Abuse Panel March 8, 2017 Panelists Greg Noonan (Moderator) Collora LLP Boston, Massachusetts Joseph F. Savage

More information

How Pharma Cos. Can Lessen The Risk Of Gov't Action

How Pharma Cos. Can Lessen The Risk Of Gov't Action Portfolio Media. Inc. 860 Broadway, 6th Floor New York, NY 10003 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com How Pharma Cos. Can Lessen The Risk Of Gov't Action

More information

PATRICK S. COFFEY. Chicago, IL office: office:

PATRICK S. COFFEY. Chicago, IL office: office: PATRICK S. COFFEY Partner Milwaukee, WI Chicago, IL office: 312.523.2080 office: 414.978.5538 email: patrick.coffey@ Overview When clients are faced with difficult problems, Pat puts them at ease. He uses

More information

This policy applies to all employees, including management, contractors, and agents. For purpose of this policy, a contractor or agent is defined as:

This policy applies to all employees, including management, contractors, and agents. For purpose of this policy, a contractor or agent is defined as: Policy and Procedure: Corporate Compliance Topic: Purpose: Choice of NY is committed to prompt, complete, and accurate billing of all services provided to individuals. Choice of NY and its employees, contractors,

More information

The False Claims Act and Financial Institutions: A New Role for an Old Statute

The False Claims Act and Financial Institutions: A New Role for an Old Statute The False Claims Act and Financial Institutions: A New Role for an Old Statute D. Jean Veta Ethan M. Posner Benjamin J. Razi July 18, 2012 Agenda 1. Background on False Claims Act 2. FCA in healthcare

More information

Effective Date: 1/01/07 N/A

Effective Date: 1/01/07 N/A North Shore-LIJ Health System is now Northwell Health POLICY TITLE: Detecting and Preventing Fraud, Waste, Abuse and Misconduct POLICY #: 800.09 System Approval Date: 03/30/2017 Site Implementation Date:

More information

SUNY DOWNSTATE MEDICAL CENTER POLICY AND PROCEDURE. No:

SUNY DOWNSTATE MEDICAL CENTER POLICY AND PROCEDURE. No: SUNY DOWNSTATE MEDICAL CENTER POLICY AND PROCEDURE Subject: Complying with the Deficit Reduction Act of 2005: Detection & Prevention of Fraud, Waste & Abuse Page 1 of 4 Prepared by: Shoshana Milstein Original

More information

The False Claims Act and Off-Label Promotion: Understanding and Minimizing the Risks for Pharmaceutical Manufacturers

The False Claims Act and Off-Label Promotion: Understanding and Minimizing the Risks for Pharmaceutical Manufacturers 4th Annual Pharmaceutical Regulatory Congress November 12, 2003 The False Claims Act and Off-Label Promotion: Understanding and Minimizing the Risks for Pharmaceutical Manufacturers John T. Bentivoglio

More information

Cardinal McCloskey Community Services. Corporate Compliance. False Claims Act and Whistleblower Provisions

Cardinal McCloskey Community Services. Corporate Compliance. False Claims Act and Whistleblower Provisions Cardinal McCloskey Community Services Corporate Compliance False Claims Act and Whistleblower Provisions Purpose: Cardinal McCloskey Community Services is committed to prompt, complete and accurate billing

More information

Fraud in the Pharmaceutical Industry

Fraud in the Pharmaceutical Industry Fraud in the Pharmaceutical Industry The United States qui tam Whistleblower Law Getnick & Getnick LLP Counsellors At Law Rockefeller Center, 620 Fifth Avenue New York, NY 10020 Phone: (212) 376-5666 Fax:

More information

Potential Perils of Using New Media in Marketing and Promotion. Christina M. Markus (202)

Potential Perils of Using New Media in Marketing and Promotion. Christina M. Markus (202) Potential Perils of Using New Media in Marketing and Promotion Christina M. Markus (202) 626-2926 cmarkus@kslaw.com FACEBOOK Using Facebook to develop online community TWITTER Using Twitter as another

More information

Will Life Sciences Companies Face More Scrutiny In 2018?

Will Life Sciences Companies Face More Scrutiny In 2018? Will Life Sciences Companies Face More Scrutiny In 2018? By John Bentivoglio and Jennifer Bragg The pace of U.S. Department of Justice settlements with life sciences companies slowed in 2017, with eight

More information

The Perils Of Pharma: The Pharmaceutical Industry And The FCPA

The Perils Of Pharma: The Pharmaceutical Industry And The FCPA W O R L D - C H E C K W H I T E P A P E R The Perils Of Pharma: The Pharmaceutical Industry And The FCPA by Michael Osajda Statement of intent In recent years, the pharmaceutical industry has been subjected

More information

Fraud and Abuse Compliance for the Health IT Industry

Fraud and Abuse Compliance for the Health IT Industry Fraud and Abuse Compliance for the Health IT Industry Session 89, March 6, 2018 James A. Cannatti III, Senior Counselor for Health Information Technology, U.S. Department of Health and Human Services (HHS),

More information

Corporate Compliance Program. Intended Audience: All SEH Associates 2016 Content Expert: Lisa Frey -

Corporate Compliance Program. Intended Audience: All SEH Associates 2016 Content Expert: Lisa Frey - Corporate Compliance Program Intended Audience: All SEH Associates 2016 Content Expert: Lisa Frey - lisa.frey@stelizabeth.com Developed 2012, reviewed Dec 2015 What is Corporate Compliance? Hospitals,

More information

FEDERAL DEFICIT REDUCTION ACT POLICY

FEDERAL DEFICIT REDUCTION ACT POLICY A. Introduction. FEDERAL DEFICIT REDUCTION ACT POLICY Partnership for Children of Essex, Inc. (referred to herein as the Organization ) has instituted this Federal Deficit Reduction Act Policy as part

More information

SOUTH NASSAU COMMUNITIES HOSPITAL One Healthy Way, Oceanside, NY 11572

SOUTH NASSAU COMMUNITIES HOSPITAL One Healthy Way, Oceanside, NY 11572 SOUTH NASSAU COMMUNITIES HOSPITAL One Healthy Way, Oceanside, NY 11572 POLICY TITLE: Compliance with Applicable Federal and State False Claims Acts POLICY NUMBER: OF-ADM-232 DEPARTMENT: Hospital-wide BACKGROUND/PURPOSE

More information

FAST BREAK: GOVERNMENT ENFORCEMENT OF INDIVIDUAL ACCOUNTABILITY. Katie McDermott Jacob Harper February 28, Morgan, Lewis & Bockius LLP

FAST BREAK: GOVERNMENT ENFORCEMENT OF INDIVIDUAL ACCOUNTABILITY. Katie McDermott Jacob Harper February 28, Morgan, Lewis & Bockius LLP FAST BREAK: 2015 Morgan, Lewis & Bockius LLP GOVERNMENT ENFORCEMENT OF INDIVIDUAL ACCOUNTABILITY Katie McDermott Jacob Harper February 28, 2017 2015 Morgan, Lewis & Bockius LLP Discussion Agenda Individual

More information

Mark Bartlett Davis Wright Tremaine LLP

Mark Bartlett Davis Wright Tremaine LLP Mark Bartlett Davis Wright Tremaine LLP The Foreign Corrupt Practices Act (FCPA) prohibits corrupt payments to foreign officials for the purpose of obtaining or keeping business Mid-1970s, series of SEC

More information

OFFICE OF INSPECTOR GENERAL WORK PLAN FISCAL YEAR 2006 MEDICARE HOSPITALS

OFFICE OF INSPECTOR GENERAL WORK PLAN FISCAL YEAR 2006 MEDICARE HOSPITALS OFFICE OF INSPECTOR GENERAL WORK PLAN FISCAL YEAR 2006 MEDICARE HOSPITALS GABRIEL L. IMPERATO, Esq. Broad & Cassel Fort Lauderdale, Fl. Medicare Hospitals Areas of Focus for OIG Work Plan 2006 Adjustments

More information

Industry Consolidation: Role of Compliance in Mergers, Acquisitions, and Divestitures

Industry Consolidation: Role of Compliance in Mergers, Acquisitions, and Divestitures Industry Consolidation: Role of Compliance in Mergers, Acquisitions, and Divestitures Prepared for CBI s Pharmaceutical Compliance Congress April 28, 2017 M&A Activity in the Pharmaceutical Industry THE

More information

This webinar is sponsored by the Fraud and Abuse Practice Group.

This webinar is sponsored by the Fraud and Abuse Practice Group. Trends in Health Care Enforcement: Past, Present, and Future July 21, 2014 3:30-4:45 Eastern This webinar is sponsored by the Fraud and Abuse Practice Group. Faculty : Susan Winkler Assistant U.S. Attorney,

More information

Coding Partners in Patient Safety

Coding Partners in Patient Safety Coding Partners in Patient Safety Senior Loss Prevention Attorney UF Self Insurance Programs Learning Objectives Understand federal fraud and abuse laws and the importance of coders in avoiding issues.

More information

Case 1:16-cr RJD Document 15 Filed 04/11/17 Page 1 of 7 PageID #: 135. F. #2016R00709 Brooklyn, New York 11201

Case 1:16-cr RJD Document 15 Filed 04/11/17 Page 1 of 7 PageID #: 135. F. #2016R00709 Brooklyn, New York 11201 Case 1:16-cr-00643-RJD Document 15 Filed 04/11/17 Page 1 of 7 PageID #: 135 U.S. Department of Justice United States Attorney Eastern District of New York JMK:JN/AES 271 Cadman Plaza East F. #2016R00709

More information

Anti-Kickback Statute and False Claims Act Enforcement

Anti-Kickback Statute and False Claims Act Enforcement Anti-Kickback Statute and False Claims Act Enforcement Nicholas Gachassin, III, Esq. Gachassin Law Firm, LLC Nick3@gachassin.com Press Conference on Health Care Fraud and the Affordable Care Act May 13,

More information

NewYork-Presbyterian Hospital Sites: All Centers Hospital Policy and Procedure Manual Number: D160 Page 1 of 8

NewYork-Presbyterian Hospital Sites: All Centers Hospital Policy and Procedure Manual Number: D160 Page 1 of 8 Page 1 of 8 TITLE: FEDERAL DEFICIT REDUCTION ACT OF 2005 FRAUD AND ABUSE PROVISIONS POLICY: NewYork- Presbyterian Hospital (NYP or the Hospital) is committed to preventing and detecting any fraud, waste,

More information

DEPARTMENT OF HEALTH AND HUMAN SERVICES. Office of Inspector General s Use of Agreements to Protect the Integrity of Federal Health Care Programs

DEPARTMENT OF HEALTH AND HUMAN SERVICES. Office of Inspector General s Use of Agreements to Protect the Integrity of Federal Health Care Programs United States Government Accountability Office Report to Congressional Requesters April 2018 DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of Inspector General s Use of Agreements to Protect the Integrity

More information

Anti-Fraud Policy. The following non-exhaustive list provides a few examples of fraud that this Policy is designed to prevent and detect:

Anti-Fraud Policy. The following non-exhaustive list provides a few examples of fraud that this Policy is designed to prevent and detect: Introduction Anti-Fraud Policy In some instances, Medicaid pays for some or all of the services provided. It is the policy of Helper s Inc. to comply with all applicable federal, state and local laws and

More information

OKALOOSA SHERIFF PRAISES WORK OF NEW MORTGAGE FRAUD TASK FORCE

OKALOOSA SHERIFF PRAISES WORK OF NEW MORTGAGE FRAUD TASK FORCE September 30, 2011 OKALOOSA SHERIFF PRAISES WORK OF NEW MORTGAGE FRAUD TASK FORCE Okaloosa County Sheriff Larry Ashley today praised the work of the newly formed Northwest Florida Mortgage Fraud Task Force,

More information

Charging, Coding and Billing Compliance

Charging, Coding and Billing Compliance GWINNETT HEALTH SYSTEM CORPORATE COMPLIANCE Charging, Coding and Billing Compliance 9510-04-10 Original Date Review Dates Revision Dates 01/2007 05/2009, 09/2012 POLICY Gwinnett Health System, Inc. (GHS),

More information

Conflicts of Interest 9/10/2017. Everything a Health Care Executive Needs to Know about the Anti-Kickback Statute. May 2, 2017 Article from JAMA:

Conflicts of Interest 9/10/2017. Everything a Health Care Executive Needs to Know about the Anti-Kickback Statute. May 2, 2017 Article from JAMA: Everything a Health Care Executive Needs to Know about the Anti-Kickback Statute Matthew Krueger Assistant United States Attorney E.D. of Wisconsin Stacy Gerber Ward von Briesen & Roper, S.C. Conflicts

More information

Region 10 PIHP FY Corporate Compliance Program Plan

Region 10 PIHP FY Corporate Compliance Program Plan Region 10 PIHP FY 2018 Corporate Compliance Program Plan 1 Mission The purpose of the Region 10 Corporate Compliance Program Plan is to provide quality care for all the individuals it serves by acting

More information

This course is designed to provide Part B providers with an overview of the Medicare Fraud and Abuse program including:

This course is designed to provide Part B providers with an overview of the Medicare Fraud and Abuse program including: This course is designed to provide Part B providers with an overview of the Medicare Fraud and Abuse program including: Medicare Trust Fund Defining Fraud & Abuse Examples of Fraud & Abuse Fraud & Abuse

More information

False Claims Act and Mandatory Disclosure Requirements for Federal Contractors

False Claims Act and Mandatory Disclosure Requirements for Federal Contractors False Claims Act and Mandatory Disclosure Requirements for Federal Contractors Presenters: Robert T. Rhoad, Esq. & Dalal Hasan, Esq. 2012 Crowell & Moring LLP All Rights Reserved False Claims Act: Recent

More information

PRODUCTS LIABILITY APPLICATION

PRODUCTS LIABILITY APPLICATION PRODUCTS LIABILITY APPLICATION Applicant s Name: Agency Name: Agent: Mailing Address: Address: Location Address: E-mail: Phone: PROPOSED EFFECTIVE DATE: From To 12:01 A.M., Standard Time at the address

More information

False Claims Act and Mandatory Disclosure Requirements for Federal Contractors

False Claims Act and Mandatory Disclosure Requirements for Federal Contractors False Claims Act and Mandatory Disclosure Requirements for Federal Contractors Presenters: Robert T. Rhoad, Esq. & Dalal Hasan, Esq. 2012 Crowell & Moring LLP All Rights Reserved False Claims Act: Recent

More information

FRAUD, WASTE, & ABUSE (FWA) for Brokers. revised 10/17

FRAUD, WASTE, & ABUSE (FWA) for Brokers. revised 10/17 FRAUD, WASTE, & ABUSE (FWA) for Brokers revised 10/17 OBJECTIVES After reviewing this information, you will be able to: Understand Fraud, Waste, and Abuse (FWA) training requirements; Be familiar with

More information

1/29/2011. Mark G. Bodner Bureau Chief Complex Civil Enforcement Bureau Medicaid Control Unit Office of the Attorney General

1/29/2011. Mark G. Bodner Bureau Chief Complex Civil Enforcement Bureau Medicaid Control Unit Office of the Attorney General Mark G. Bodner Bureau Chief Complex Civil Enforcement Bureau Medicaid Control Unit Office of the Attorney General The enactment of the Medicare and Medicaid Anti-Fraud and Abuse Amendments of 1977 authorized

More information

False Claims Act Enforcement in the Managed Care Space: Recent Trends and Proactive Compliance Tips

False Claims Act Enforcement in the Managed Care Space: Recent Trends and Proactive Compliance Tips False Claims Act Enforcement in the Managed Care Space: Recent Trends and Proactive Compliance Tips Thomas Clarkson* U.S. Attorney s Office Southern District of Georgia Scott R. Grubman Chilivis Cochran

More information

The Anesthesia Company Model: Frequently Asked Questions

The Anesthesia Company Model: Frequently Asked Questions The Anesthesia Company Model: Frequently Asked Questions 1. What is the situation in Florida? Florida-specific Issues For several years, FSA members have been contacting the society with reports of company

More information

DEFICIT REDUCTION ACT AND FALSE CLAIMS POLICY INFORMATION FOR All NEW YORK WORKFORCE MEMBERS

DEFICIT REDUCTION ACT AND FALSE CLAIMS POLICY INFORMATION FOR All NEW YORK WORKFORCE MEMBERS DEFICIT REDUCTION ACT AND FALSE CLAIMS POLICY INFORMATION FOR All NEW YORK WORKFORCE MEMBERS The Company is committed to preventing health care fraud, waste and abuse and complying with applicable state

More information

Policy to Provide Information for Combating Fraud, Waste and Abuse and the Ability of Employees to Report Wrongdoing

Policy to Provide Information for Combating Fraud, Waste and Abuse and the Ability of Employees to Report Wrongdoing 1 of 8 and Abuse and the Ability of Employees to Report Wrongdoing 1. Purpose The purpose of this policy is to provide information for combating fraud, waste and abuse and the ability of employees to report

More information

United States Department of Justice Foreign Corrupt Practices Act Initiative for Pharmaceutical and Medical Device Manufacturers

United States Department of Justice Foreign Corrupt Practices Act Initiative for Pharmaceutical and Medical Device Manufacturers United States Department of Justice Foreign Corrupt Practices Act Initiative for Pharmaceutical and Medical Device Manufacturers The Tenth Annual Pharmaceutical Regulatory and Compliance Congress and Best

More information

False Claims Liability, Anti-Retaliation Protections, and Detecting and Responding to Fraud, Waste, and Abuse

False Claims Liability, Anti-Retaliation Protections, and Detecting and Responding to Fraud, Waste, and Abuse False Claims Liability, Anti-Retaliation Protections, and Detecting and Responding to Fraud, Waste, and 1. SCOPE 1.1 System-wide, including Marshfield Clinic Health System (MCHS), Inc. and its affiliated

More information

The Foreign Corrupt Practices Act: Effective Compliance Strategies ACC In-House Counsel Forum April 28, 2011

The Foreign Corrupt Practices Act: Effective Compliance Strategies ACC In-House Counsel Forum April 28, 2011 The Foreign Corrupt Practices Act: Effective Compliance Strategies ACC In-House Counsel Forum April 28, 2011 T. MARKUS FUNK (Moderator) Partner, Perkins Coie Federal Prosecutor (Chicago) 2000-10 USDOJ

More information

False Claims Prevention

False Claims Prevention False Claims Prevention POLICY STATEMENT It is the policy of Atrium Health & Senior Living ( Atrium ) to put into practice procedures designed to detect and prevent fraud, waste and abuse, and to maintain

More information

U.S. v. Sulzbach: Government Theories, Potential Defenses, and Lessons Learned

U.S. v. Sulzbach: Government Theories, Potential Defenses, and Lessons Learned U.S. v. Sulzbach: Government Theories, Potential Defenses, and Lessons Learned Presented By: David O Brien Christine Rinn Michael Paddock HOOPS 2007 - Washington, DC October 15-16 Background June 1994:

More information

The False Claims Act. False Claims Act Basics (I)

The False Claims Act. False Claims Act Basics (I) The False Claims Act Basic Concepts, Recent Trends, and Strategies for Minimizing Risks Philip D. Robben February 26, 2013 False Claims Act Basics (I)! Imposes liability on those who submit false claims

More information

DEFICIT REDUCTION ACT AND FALSE CLAIMS POLICY INFORMATION FOR All MASSACHUSETTS WORKFORCE MEMBERS

DEFICIT REDUCTION ACT AND FALSE CLAIMS POLICY INFORMATION FOR All MASSACHUSETTS WORKFORCE MEMBERS DEFICIT REDUCTION ACT AND FALSE CLAIMS POLICY INFORMATION FOR All MASSACHUSETTS WORKFORCE MEMBERS The Company is committed to preventing health care fraud, waste and abuse and complying with applicable

More information

Health Care Compliance

Health Care Compliance Health Care Compliance Communiqué New Rules for Individual Accountability.............. 1 New Rules for Donations in China................... 4 Procurement Fraud and Supply Chain Risk........... 6 NEW

More information

The SEC Whistleblower Law and Pharma Manufacturing in the US and Abroad Neil V. Getnick

The SEC Whistleblower Law and Pharma Manufacturing in the US and Abroad Neil V. Getnick Blowing the Whistle on cgmps: the Next Big Challenge for Compliance The SEC Whistleblower Law and Pharma Manufacturing in the US and Abroad Neil V. Getnick PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS

More information

Contractors in the Crosshairs: Investigations Passing Government Scrutiny

Contractors in the Crosshairs: Investigations Passing Government Scrutiny Westlaw Journal Government Contract Litigation News and Analysis Legislation Regulation Expert Commentary VOLUME 29, issue 4 / june 22, 2015 Expert Analysis Contractors in the Crosshairs: Investigations

More information

Clinical and Administrative Policies and Procedures

Clinical and Administrative Policies and Procedures Clinical and Administrative Policies and Procedures Purpose: Centerstone is committed to its role in preventing health care fraud and abuse and complying with applicable state and federal law related to

More information

HUDSON SPECIALTY INSURANCE COMPANY Employed Ancillary Provider Application for surplus lines coverage

HUDSON SPECIALTY INSURANCE COMPANY Employed Ancillary Provider Application for surplus lines coverage HUDSON SPECIALTY INSURANCE COMPANY Employed Ancillary Provider Application for surplus lines coverage - If a question does not apply to you, write N/A. Do not leave any questions unanswered. - Include

More information

Institute of Internal Auditors 2018 IIA CHICAGO CHAPTER JOIN NTAC:4UC-11

Institute of Internal Auditors 2018 IIA CHICAGO CHAPTER JOIN NTAC:4UC-11 IIA CHICAGO CHAPTER JOIN US: @IIACHI UNDERSTANDING THE FCPA: RECENT TRENDS AND CONSIDERATIONS PRESENTED BY: ALI RAMPURAWALA, MANAGER MUMTA TANEJA, MANAGER AGENDA Overview of Foreign Corrupt Practices Act

More information

R E P R I N T JAN-MAR Inside this issue: The evolving role of the chief risk officer Managing your company s regulatory exposure

R E P R I N T JAN-MAR Inside this issue: The evolving role of the chief risk officer Managing your company s regulatory exposure R E P R I N T RC & risk compliance & NEW DOJ POLICIES MAY HELP COMPANIES BETTER NAVIGATE FALSE CLAIMS ACT INVESTIGATIONS REPRINTED FROM: RISK & COMPLIANCE MAGAZINE OCT-DEC 2018 ISSUE RC & risk & compliance

More information

Federal Deficit Reduction Act of 2005, Section 6032 on Fraud, Waste, and Abuse

Federal Deficit Reduction Act of 2005, Section 6032 on Fraud, Waste, and Abuse Policy Number: 4003 Page: 1 of 8 POLICY: It is the policy of Bridgeway Rehabilitation Services, Inc. to obey all federal and state laws and to implement and enforce procedures to detect and prevent fraudulent

More information

Protecting the Navy from Acquisition Fraud Through Detection, Deterrence and Recovery

Protecting the Navy from Acquisition Fraud Through Detection, Deterrence and Recovery Protecting the Navy from Acquisition Fraud Through Detection, Deterrence and Recovery AIO Mission Provide a Department of the Navy wide program to deter fraud to the maximum extent possible, detect fraud

More information

C. Enrollees: A Medicaid beneficiary who is currently enrolled in the MCCMH PIHP.

C. Enrollees: A Medicaid beneficiary who is currently enrolled in the MCCMH PIHP. professionally recognized standards for health care. It also includes beneficiary practices that result in unnecessary cost to the Medicaid program. 42 CFR 455.2 B. CMS: Centers for Medicare & Medicaid

More information

Effective Date: 5/31/2007 Reissue Date: 10/08/2018. I. Summary of Policy

Effective Date: 5/31/2007 Reissue Date: 10/08/2018. I. Summary of Policy Issuing Department: Internal Audit, Compliance, and Enterprise Risk Management Preventing Fraud, Waste, and Abuse: Federal and State False Claims and False Statements Effective Date: 5/31/2007 Reissue

More information

Whistleblowing Under the False Claims Act

Whistleblowing Under the False Claims Act Whistleblowing Under the False Claims Act Session 303, March 9, 2018 Colette G. Matzzie, Partner, Phillips & Cohen LLP Brendan Delaney, Implementation Specialist, Whistleblower 1 Conflict of Interest Colette

More information

The Foreign Corrupt Practices Act (FCPA): Doing Business Internationally. Washington, DC August 21, 2014

The Foreign Corrupt Practices Act (FCPA): Doing Business Internationally. Washington, DC August 21, 2014 The Foreign Corrupt Practices Act (FCPA): Doing Business Internationally Washington, DC August 21, 2014 Agenda 1. Overview of the FCPA 2. FCPA Enforcement Trends 3. The In-House View and Corruption Red

More information

City/State: From: To: City/State: From: To: City/State: From: To:

City/State: From: To: City/State: From: To: City/State: From: To: 2. If you are currently insured on a claims-made policy, are you obtaining Extended Reporting Period (tail) from your current insurance carrier? Yes No N/A (have occurrence coverage now) Note: To prevent

More information

Bribery and Corruption

Bribery and Corruption Bribery and Corruption The FCPA, UK Bribery Act, and Other Anti-Corruption Measures 2018 Association of Certified Fraud Examiners, Inc. Introduction The FCPA and the UK Bribery Act are the two premier

More information

COMPLIANCE OF THE UNITED STATES OF AMERICA THE INTER-AMERICAN CONVENTION AGAINST CORRUPTION REPORT OF CIVIL SOCIETY COMMITTEE OF EXPERTS WITH TO THE

COMPLIANCE OF THE UNITED STATES OF AMERICA THE INTER-AMERICAN CONVENTION AGAINST CORRUPTION REPORT OF CIVIL SOCIETY COMMITTEE OF EXPERTS WITH TO THE COMPLIANCE OF THE UNITED STATES OF AMERICA WITH THE INTER-AMERICAN CONVENTION AGAINST CORRUPTION REPORT OF CIVIL SOCIETY TO THE COMMITTEE OF EXPERTS AUGUST 13, 2010 COMMITTEE OF EXPERTS OF THE FOLLOW-UP

More information

Beazley Remedy New Business Regulatory Liability Application

Beazley Remedy New Business Regulatory Liability Application Beazley Remedy New Business Regulatory Liability Application THE APPLICABLE LIMITS OF LIABILITY AND ARE SUBJECT TO THE RETENTIONS. PLEASE READ THIS POLICY CAREFULLY. Please fully answer all questions and

More information

CHUBB Recall Plus SM. Consumable Products Application Form

CHUBB Recall Plus SM. Consumable Products Application Form CHUBB Recall Plus SM Please answer the following questions to provide Chubb with the information necessary to properly evaluate your product recall insurance. This information is not only vital for evaluating

More information

Eric B. Bruce Lawyer WASHINGTON DC NEW YORK. Admissions

Eric B. Bruce Lawyer WASHINGTON DC NEW YORK. Admissions Eric B. Bruce Lawyer WASHINGTON DC 1919 M Street, NW Washington, DC 20036 +1 202 664 1903 NEW YORK 800 Third Avenue New York, New York 10022 +1 212 488 1203 eric.bruce@kobrekim.com A former high-ranking

More information

SESSION OVERVIEW The Yates Memo and its Legal Implications in Corporate Investigations.

SESSION OVERVIEW The Yates Memo and its Legal Implications in Corporate Investigations. COMPLIANCE CHALLENGES IN THE YATES MEMO ERA HCCA S 21 ST ANNUAL COMPLIANCE INSTITUTE, March 27, 2017 Gina Simms, Esq. George Breen, Esq. Tarra DeShields, AUSA District of Maryland SESSION OVERVIEW The

More information

MFA COMPLIANCE 2016: UNDERSTANDING INSURANCE AND LIABILITY: A FOCUS ON D&O, CYBERSECURITY AND POLICY REVIEWS

MFA COMPLIANCE 2016: UNDERSTANDING INSURANCE AND LIABILITY: A FOCUS ON D&O, CYBERSECURITY AND POLICY REVIEWS MFA COMPLIANCE 2016: UNDERSTANDING INSURANCE AND LIABILITY: A FOCUS ON D&O, CYBERSECURITY AND POLICY REVIEWS Presented by: Lynda A. Bennett Chair, Insurance Recovery Group LOWENSTEIN SANDLER LLP 973.597.6338

More information

JAMAICA HOSPITAL MEDICAL CENTER

JAMAICA HOSPITAL MEDICAL CENTER JAMAICA HOSPITAL MEDICAL CENTER COMMITMENT TO COMPLIANCE CODE OF CONDUCT AND COMPLIANCE PROGRAM SUMMARY SEPTEMBER 2009 REVIEWED: 3/12, 9/13, 5/14, 6/15 REVISED: 8/12, 8/16, 7/17, 2/18 COMMITMENT TO COMPLIANCE

More information

The Impact of the Fraud and Abuse Laws on Pharmaceutical Advertising and Marketing Compliance: A Manufacturer s Perspective

The Impact of the Fraud and Abuse Laws on Pharmaceutical Advertising and Marketing Compliance: A Manufacturer s Perspective International In-house Counsel Journal Vol. 4, No. 13, Autumn 2010, 1 The Impact of the Fraud and Abuse Laws on Pharmaceutical Advertising and Marketing Compliance: A Manufacturer s Perspective LESLIE

More information

Federal Fraud and Abuse Enforcement in the ASC Space

Federal Fraud and Abuse Enforcement in the ASC Space Federal Fraud and Abuse Enforcement in the ASC Space SCOTT R. GRUBMAN, ESQ. PARTNER CHILIVIS COCHRAN LARKINS & BEVER, LLP (ATLANTA GA) Fraud & Abuse Enforcement Landscape FBI CMS OCR MFCU DCIS DOJ HHS-OIG

More information

DOJ OPINION LIMITING THE SCOPE OF CRIMINAL ENFORCEMENT UNDER HIPAA ISSUED JUNE 1, Houston (832) (800)

DOJ OPINION LIMITING THE SCOPE OF CRIMINAL ENFORCEMENT UNDER HIPAA ISSUED JUNE 1, Houston (832) (800) DOJ OPINION LIMITING THE SCOPE OF CRIMINAL ENFORCEMENT UNDER HIPAA ISSUED JUNE 1, 2005 By: Katherine M. Layman, Esquire, Brad M. Rostolsky, Esquire 1900 Market Street Philadelphia PA, 19103 215.665.2000

More information

LAWS AND REQUIREMENTS

LAWS AND REQUIREMENTS I Section LAWS AND REQUIREMENTS FOR COMPLIANCE The chapters in this section explore the most significant laws on which healthcare compliance programs are focused. These are the laws with which they are

More information

6/2015. Hospital Board Training Part 2: Laws Every Board Member Should Know. Holland & Hart LLP

6/2015. Hospital Board Training Part 2: Laws Every Board Member Should Know. Holland & Hart LLP Hospital Board Training Part 2: Laws Every Board Member Should Know (6-16) This presentation is similar to any other legal education materials designed to provide general information on pertinent legal

More information

State False Claims Acts

State False Claims Acts State False Claims Acts How States Can Recover Stolen Money Jim Moorman, TAF Roderick Chen, OIG-HHS The Scope of the Fraud No one knows for sure how much fraud infects Medicaid and Medicare. The U.S. Government

More information

Case 1:17-cr AT-CMS Document 7 Filed 09/28/17 Page 1 of 18

Case 1:17-cr AT-CMS Document 7 Filed 09/28/17 Page 1 of 18 Case 1:17-cr-00229-AT-CMS Document 7 Filed 09/28/17 Page 1 of 18 ORIGINAL FILED IN OPEN COURT U.S.D.C, Atlanta SEP 2 8 2017 i IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF GEORGIA ATLANTA

More information

Trade Secret Theft: Protecting the Crown Jewels March 25, 2015

Trade Secret Theft: Protecting the Crown Jewels March 25, 2015 Trade Secret Theft: Protecting the Crown Jewels March 25, 2015 Presented by: Dan Rubinstein Today s elunch Presenter Dan Rubinstein Litigation Chicago, Los Angeles drubinstein@winston.com 2 Trade Secret

More information

Brazil s Clean Company Act: How U.S., U.K., and Global Models May Influence Enforcement

Brazil s Clean Company Act: How U.S., U.K., and Global Models May Influence Enforcement Brazil s Clean Company Act: How U.S., U.K., and Global Models May Influence Enforcement July 14, 2014 1) Introduction Brazil s new anti-bribery law (Law no. 12.846/2013), often referred to as the Clean

More information

Is BAE Systems Too Big To Fail?

Is BAE Systems Too Big To Fail? Portfolio Media, Inc. 860 Broadway, 6 th Floor New York, NY 10003 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@portfoliomedia.com Is BAE Systems Too Big To Fail? Law360, New

More information

Voya Financial Anti-Corruption and Anti-Bribery Policy

Voya Financial Anti-Corruption and Anti-Bribery Policy Voya Financial Anti-Corruption and Anti-Bribery Policy Version 2.0 April 2014 Information Sheet ISSUED BY Voya Financial Compliance OWNED AND APPROVED BY Board of Voya Financial TARGET AUDIENCE All Voya

More information

Analysis of the New Medicare Part D Drug Benefit and Changes to Medicare Part B Reimbursement: New Rules of the Road

Analysis of the New Medicare Part D Drug Benefit and Changes to Medicare Part B Reimbursement: New Rules of the Road National Medicare Prescription Drug Congress Analysis of the New Medicare Part D Drug Benefit and Changes to Medicare Part B Reimbursement: New Rules of the Road T. Reed Stephens Health Care Practice Group

More information

UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS. Case No.:

UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS. Case No.: Case 1:16-cv-10471-MPK Document 1 Filed 03/07/16 Page 1 of 21 UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS MATTHEW CRANDALL, Individually and on Behalf of all Others Similarly Situated, Plaintiff,

More information

THE NEW YORK FOUNDLING

THE NEW YORK FOUNDLING THE NEW YORK FOUNDLING COMMITMENT TO COMPLIANCE HANDBOOK CODE OF CONDUCT AND COMPLIANCE STANDARDS COMPLIANCE PROGRAM STRUCTURE AND GUIDELINES POLICIES AND PROCEDURES December 2012 COMMITMENT TO COMPLIANCE

More information

2017 Year-End Review: Anti-Corruption Trends and Other Corporate Enforcement Issues

2017 Year-End Review: Anti-Corruption Trends and Other Corporate Enforcement Issues 2017 Year-End Review: Anti-Corruption Trends and Other Corporate Enforcement Issues January 25, 2018 Davis Polk & Wardwell LLP CLE CREDIT AVAILABLE Agenda 2017 Facts and Figures DOJ Developments FCPA Corporate

More information

MEDISYS AMBULANCE SERVICES, INC.

MEDISYS AMBULANCE SERVICES, INC. MEDISYS AMBULANCE SERVICES, INC. COMMITMENT TO COMPLIANCE CODE OF CONDUCT AND COMPLIANCE PROGRAM SUMMARY OCTOBER 2009 REVIEWED: 4/12, 10/13, 5/14, 6/15 REVISED: 8/12, 8/16, 7/17, 2/18 COMMITMENT TO COMPLIANCE

More information

Anti-Money Laundering and U.S. Compliance

Anti-Money Laundering and U.S. Compliance U.S. Regulatory/Compliance Orientation for International Bankers Anti-Money Laundering and U.S. Compliance Conference of State Bank Supervisors & Institute of International Bankers New York City, New York

More information

DAVID MAKOL, being duly sworn, deposes and says that he is a Special Agent of the Federal Bureau of Investigation, and charges as follows: COUNT ONE

DAVID MAKOL, being duly sworn, deposes and says that he is a Special Agent of the Federal Bureau of Investigation, and charges as follows: COUNT ONE Approved: MICHAEL S. SCHACHTER Assistant United States Attorney Before: HONORABLE GABRIEL W. GORENSTEIN United States Magistrate Judge Southern District of New York - - - - - - - - - - - - - - - - - -

More information

FAQ: Federal Regulations and Coding Compliance

FAQ: Federal Regulations and Coding Compliance Question 1: Why is coding compliance important? Answer 1: Coding compliance is part of the overall effort of medical practices to comply with regulations in the coding area. Compliant claims are an indication

More information

MEMORANDUM OF UNDERSTANDING

MEMORANDUM OF UNDERSTANDING Activities of the Health and Human Services Commission and the Office of the Attorney General in Detecting and Preventing Fraud, Waste, and Abuse in the State Medicaid Program MEMORANDUM OF UNDERSTANDING

More information

Managing Financial Interests: The Anti Kickback Statute (AKS)

Managing Financial Interests: The Anti Kickback Statute (AKS) Managing Financial Interests: The Anti Kickback Statute (AKS) Board of Commissioners Meeting February 15, 2012 Presented by: Mic Sager, Compliance Officer Context: Business Transactions o Health Care is

More information

Anti-fraud and Corruption Policy

Anti-fraud and Corruption Policy Anti-fraud and Corruption Policy Responsible Division: Finances Validated by: Board (Executive Committee) Date of approval: 17/05/2017 Date of next review: May 2019 Language versions available: English

More information

Advisory. Connecticut False Claims Act: A New Arrow in the Quiver of State Regulators

Advisory. Connecticut False Claims Act: A New Arrow in the Quiver of State Regulators Advisory HEALTH CARE COMPLIANCE PRACTIC E GR OUP I OCTOBE R 2009 A New Arrow in the Quiver of State Regulators On October 5, 2009, Governor Rell signed a civil False Claims Act into law. Connecticut s

More information

What Every European Company Should Know About the FCPA and the UK Bribery Act

What Every European Company Should Know About the FCPA and the UK Bribery Act November 16, 2011 What Every European Company Should Know About the FCPA and the UK Bribery Act Eric Kraeutler, Litigation Practice, Philadelphia Olivier Edwards, Business and Finance Practice, Paris Jürgen

More information

Code of Conduct U.S. Supplemental Requirements

Code of Conduct U.S. Supplemental Requirements Our commitment to caring and curing Code of Conduct U.S. Supplemental Requirements US CoC Supplement_V6.indd 2 12/10/2011 10:05 Introduction These U.S. Supplemental Requirements to the Novartis Code of

More information

This Webcast Will Begin Shortly

This Webcast Will Begin Shortly Page 1 This Webcast Will Begin Shortly If you have any technical problems with the Webcast or the streaming audio, please contact us via email at: accwebcast@commpartners.com Thank You! Foreign Corrupt

More information